{{Rsnum
|rsid=4499545
|Gene=ROPN1
|Chromosome=3
|position=123986995
|Orientation=plus
|GMAF=0.1589
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ROPN1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 23.9 | 73.5
| HCB | 0.7 | 21.3 | 77.9
| JPT | 0.0 | 9.9 | 90.1
| YRI | 4.1 | 34.0 | 61.9
| ASW | 12.5 | 21.4 | 66.1
| CHB | 0.7 | 21.3 | 77.9
| CHD | 2.8 | 19.3 | 78.0
| GIH | 3.0 | 23.8 | 73.3
| LWK | 5.5 | 35.8 | 58.7
| MEX | 0.0 | 17.9 | 82.1
| MKK | 6.6 | 39.1 | 54.3
| TSI | 5.9 | 33.3 | 60.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20107840
|Title=Kalirin: a novel genetic risk factor for ischemic stroke
}}

{{PMID Auto
|PMID=17357071
|Title=Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | Affy GenomeWide 6}}